EN PL
  1. www.sciencepharma.com
  2. News
  3. Clinical/Medical
  4. URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 28, 2015 concerning the new recommendations aimed at minimizing the risk of a rare infection PML, and one of the types

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 28, 2015 concerning the new recommendations aimed at minimizing the risk of a rare infection PML, and one of the types

11.01.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 28, 2015 concerning the new recommendations aimed at minimizing the risk of a rare infection PML, and one of the types of skin cancer in the case of a medicinal product Gilenya.
The source of the news: http://www.urpl.gov.pl/aktualnosci/informacja-z-dnia-28-12-2015r-w-sprawie-nowych-zalecen-majacych-na-celu-zminimalizowanie-ryzyka-wystapienia-rzadkiego-zakazenia-pml-oraz-jednego-z-rod